Featured News

Today, the U.S. Food and Drug Administration issued a final rule for gluten-free labeling compliance requirements for fermented and hydrolyzed foods.

I want to share with you an update of our work in Washington, DC with Congress and NIH to accelerate research for diagnostics, treatments, and a cure for celiac disease.

A recent study from the United Kingdom found changes in the brains of celiac patients, linking them with mental health problems. 

EpiLynx Skin Care and Cosmetics is proud to announce its sponsorship with the Celiac Disease Foundation. Dr. Liia, founder of EpiLynx, dedicated herself to making gluten-free, allergen-free skincare that is not only safe but transforms the skin.

Thanks to your generous support, we are deploying iCureCeliac and iQualifyCeliac, as well as other assets unique to the Foundation, to further celiac disease drug development.

The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.

To guarantee the safety & comfort of our community, we have decided to take our 2020 CDF Turkey Trot virtual. Whether you’re 5 or 55, a marathoner or just starting your fitness journey, anyone can participate from anywhere!

Concern has been expressed in the celiac disease community that the FDA’s temporary food labeling requirements during COVID-19 apply to gluten. The FDA confirmed that the introduction of unlabeled gluten is not allowed in regulated food products.

We are pleased to announce our newest online resource for patients and caregivers to drive policy change to improve the health of those living with celiac disease and accelerate research: iAdvocate.

CDF has been approved for a $100,000 funding award through the Eugene Washington PCORI Engagement Awards program. The funds will support the community convening of patient advocates, researchers, and other key stakeholders to create a roadmap for patient advocate engagement in research.